Index
-
Market Cap
12.91B
Enterprise Value
16.30B
Income
-199.00M
Sales
5.02B
Book/sh
13.19
Cash/sh
1.06
Dividend Est.
-
Dividend TTM
-
Dividend Ex-Date
-
Dividend Gr. 3/5Y
- -
Payout
-
Employees
9900
IPO
Sep 20, 2018
P/E
-
Forward P/E
20.42
PEG
1.37
P/S
2.57
P/B
1.96
P/C
24.35
P/FCF
34.06
EV/EBITDA
15.88
EV/Sales
3.25
Quick Ratio
1.10
Current Ratio
2.05
Debt/Eq
0.59
LT Debt/Eq
0.58
Option/Short
Yes / Yes
EPS (ttm)
-0.40
EPS next Y
1.27
EPS next Q
0.18
EPS this Y
20.42%
EPS next Y
11.79%
EPS next 5Y
14.89%
EPS past 3/5Y
-43.04% 18.11%
Sales past 3/5Y
2.25% 7.57%
EPS Y/Y TTM
-145.71%
Sales Y/Y TTM
11.95%
EPS Q/Q
380.63%
Sales Q/Q
10.23%
Insider Own
1.02%
Insider Trans
1.37%
Inst Own
114.71%
Inst Trans
4.43%
ROA
-1.46%
ROE
-2.98%
ROIC
-1.91%
Gross Margin
44.28%
Oper. Margin
6.63%
Profit Margin
-3.96%
SMA20
10.73%
SMA50
11.68%
SMA200
8.55%
Trades
Shs Outstand
499.55M
Shs Float
494.51M
52W High
27.98 -7.67%
52W Low
19.40 33.17%
Volatility
4.11% 3.19%
ATR (14)
0.92
RSI (14)
65.53
Beta
1.69
Rel Volume
1.68
Avg Volume
6.04M
Volume
5,517,056
Perf Week
12.03%
Perf Month
14.62%
Perf Quarter
15.96%
Perf Half Y
9.24%
Perf YTD
14.16%
Perf Year
20.05%
Perf 3Y
176.01%
Perf 5Y
-24.22%
Perf 10Y
-
Prev Close
23.68
Price
25.83
Change %
9.10%
Analysts 14 incl. previous ratings
Rating Distribution 12 Buy · 2 Hold · 0 Sell
Date Action Analyst Rating Change Price Target Change Implied Upside Oct 20, 2026 Downgrade J Jefferies
Buy → Hold $24 -7.1% Oct 16, 2026 Initiated G Goldman
Buy $32 +23.9% Apr 15, 2026 Initiated C Citigroup
Buy $30 +16.1% Jan 22, 2026 Upgrade P Piper Sandler
Neutral → Overweight Dec 09, 2025 Initiated B Barclays
Overweight $30 +16.1% Nov 21, 2025 Initiated K KeyBanc Capital Markets
Overweight $27 +4.5% Nov 19, 2025 Upgrade A Argus
Hold → Buy $25 -3.2% Oct 07, 2025 Upgrade J JP Morgan
Neutral → Overweight $24 -7.1% Jul 17, 2025 Upgrade L Leerink Partners
Market Perform → Outperform $18 -30.3% Jun 26, 2025 Upgrade W William Blair
Mkt Perform → Outperform Dec 09, 2024 Initiated U UBS
Buy $18 -30.3% Dec 02, 2024 Initiated L Leerink Partners
Market Perform $14 -45.8% Sep 19, 2024 Downgrade M Morgan Stanley
Overweight → Equal-Weight $17 → $15 -41.9% Jan 05, 2024 Upgrade S Stifel
Hold → Buy $13 → $20 -22.6% Dec 19, 2023 Initiated J Jefferies
Buy $17 -34.2% Dec 15, 2023 Upgrade M Morgan Stanley
Equal-Weight → Overweight $16 -38.1% Dec 07, 2023 Initiated E Exane BNP Paribas
Outperform $18 -30.3% Apr 20, 2023 Upgrade B Barclays
Equal Weight → Overweight $14 -45.8% Aug 18, 2022 Downgrade M Morgan Stanley
Overweight → Equal-Weight $37 → $22 -14.8% Aug 16, 2022 Downgrade J JP Morgan
Overweight → Neutral $28 → $24 -7.1%
Show Previous Ratings
Today 10:46AM
(Earnings Whispers)
+9.10%
07:57AM
06:27AM
06:27AM
05:00AM
03:38AM
Loading…
03:38AM
Nov-03-26 07:53AM
Oct-29-26 01:58PM
09:30AM
Oct-27-26 09:30AM
Oct-22-26 06:53AM
Oct-20-26 09:06AM
Oct-19-26 04:00PM
Oct-14-26 11:30AM
Oct-07-26 11:30AM
07:57AM
Loading…
Sep-17-26 07:57AM
Sep-15-26 12:05PM
Sep-11-26 07:58AM
Sep-10-26 01:05PM
07:58AM
Aug-31-26 09:30AM
Aug-26-26 11:59PM
(St. Joseph News-Press, Mo.)
08:30AM
Aug-07-26 02:20PM
Aug-06-26 05:33PM
Aug-05-26 03:01PM
06:27AM
Jul-31-26 07:32AM
Jul-22-26 06:27AM
Jul-08-26 08:00AM
07:26AM
Loading…
Jun-18-26 07:26AM
Jun-15-26 08:47AM
Jun-04-26 01:47PM
(The Wall Street Journal)
10:23AM
06:26AM
Jun-03-26 07:26AM
May-18-26 07:27AM
May-14-26 08:00AM
May-06-26 08:12AM
06:27AM
Apr-27-26 06:23PM
Apr-16-26 08:00AM
Apr-15-26 09:47AM
Apr-13-26 04:08PM
Apr-09-26 08:27AM
Mar-23-26 01:38PM
Mar-16-26 03:23PM
Feb-26-26 09:56AM
Feb-24-26 04:22PM
03:08PM
02:01PM
11:25AM
09:30AM
08:15AM
06:38AM
06:27AM
Feb-23-26 10:57AM
Feb-22-26 10:06PM
Feb-19-26 09:15AM
08:00AM
Feb-13-26 09:24AM
Feb-10-26 06:41AM
Jan-30-26 11:56AM
Jan-28-26 07:50AM
Jan-27-26 04:04PM
Jan-26-26 11:35PM
Jan-22-26 04:36PM
08:00AM
06:00AM
(The Wall Street Journal)
Jan-12-26 06:54PM
Jan-06-26 11:08PM
06:52PM
08:00AM
Dec-31-25 02:00PM
Dec-21-25 10:07AM
Dec-19-25 01:30AM
Dec-18-25 08:43AM
Dec-16-25 02:05PM
09:40AM
Dec-12-25 12:00PM
Dec-09-25 04:15PM
(Investor's Business Daily)
-5.81%
07:40AM
Nov-24-25 07:00PM
Nov-21-25 01:35PM
Nov-20-25 08:00AM
Nov-14-25 09:03AM
Nov-13-25 08:00AM
Nov-12-25 12:35AM
Nov-11-25 08:46AM
Nov-06-25 12:33AM
Nov-05-25 07:26PM
03:12PM
02:01PM
09:30AM
07:35AM
06:36AM
06:27AM
Nov-03-25 10:19PM
04:28PM
(Investor's Business Daily)
Oct-29-25 10:00AM
Show Previous News
Insider Trading
Relationship
Date
Transaction
Cost
#Shares
Value ($)
#Shares Total
SEC Form 4
Bettington Timothy J SEE REMARKS Oct 15 '26 Sale 23.00 4,350 100,050 138,911 Oct 19 04:15 PM Bettington Timothy J Officer Oct 15 '26 Proposed Sale 23.00 4,350 100,050 Oct 15 04:01 PM Kurzius Lawrence Erik Director Aug 20 '26 Buy 23.40 40,000 935,920 188,647 Aug 21 04:16 PM O'Neill Shiv GC AND CORP SEC Aug 18 '26 Buy 23.58 3,998 94,273 87,832 Aug 18 04:32 PM Harrington Michael J Director Aug 12 '26 Buy 21.82 5,000 109,100 131,451 Aug 13 04:28 PM VanHimbergen Robert M EVP and CFO Aug 07 '26 Buy 23.08 4,200 96,926 137,516 Aug 10 04:14 PM Herendeen Paul Director Aug 07 '26 Buy 23.68 10,000 236,850 111,687 Aug 10 04:13 PM Modi Rajeev A. SEE REMARKS May 15 '26 Buy 20.35 4,911 99,939 160,812 May 19 04:39 PM Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR May 15 '26 Buy 20.09 4,971 99,843 171,971 May 19 04:38 PM Kurzius Lawrence Erik Director Dec 12 '25 Buy 21.30 10,000 213,000 131,773 Dec 16 04:42 PM Modi Rajeev A. SEE REMARKS Dec 11 '25 Buy 21.33 4,500 95,985 123,082 Dec 15 04:43 PM VanHimbergen Robert M EVP and CFO Dec 11 '25 Buy 21.64 6,950 150,426 124,233 Dec 15 04:42 PM Simmons Jeffrey N PRESIDENT, CEO AND DIRECTOR Dec 11 '25 Buy 21.75 22,000 478,496 167,000 Dec 15 04:41 PM
Elanco Animal Health, Inc. develops, manufactures, and markets products for pets and farm animals. Its products include Advantage Family, Atopica, Credelio Family, Drontal Family, Galliprant, Interceptor Plus, Milbemax, Onsior, Seresto, Trifexis, TruCan, AviPro, Baytril, Catosal, Denagard, and Experior. The company was founded in 1954 and is headquartered in Indianapolis, IN.
President Mr. Jeffrey N. Simmons
Executive VP & CFO Mr. Robert M. VanHimbergen
Executive VP & President of Elanco International Dr. Ramiro Martin Cabral
Executive Vice President of Research Dr. Ellen de Brabander Ph.D.
Executive Vice President of Center of Strategic Growth Mr. Timothy J. Bettington